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multiple sample assessments was limited and considered acceptable in the
context of logistics, scarcity of samples, and costs (triplicate assessment in
a subset of samples showed high correlation between biochemical marker
concentrations in the ﬁrst sample and the mean concentration in triplets; rs
0.841 - 0.996, P 0.000). Of the 11,000 assessments that were performed, 27
and 19 assessments showed concentrations that were below and above the
standard curve, respectively. Re-assessment in adjusted dilutions induced
(unpredictable) non-linear dilution effects and was considered inappro-
priate. Instead, artiﬁcial concentrations (0.8×minimum, 1.2×maximum
concentration) were used. Technically-induced variability increased stepwise
between the 3 levels (intra-plate<within day<total), but not statistically
signiﬁcantly. Correction for between-plate variability on the basis of compar-
ison of the standard sample assessment between assay plates decreased the
mean sum of squared differences between plates by a factor 1.5 (mean; SD
0.9). Three of the 11 biomarkers showed unanticipated results. One could be
re-assessed successfully, the other 2 remained unsolved, despite thorough
analyses in consultancy with the manufacturer.
Conclusions: Large-scale and broad-spectrum biochemical marker assess-
ment poses speciﬁc challenges. However, this study shows that large-scale
assessment was feasible for the vast majority of the studied biochemical
markers.
This study was funded by CHECK (Cohort Hip & Cohort Knee), an initiative
of the Dutch Arthritis Association.
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IMPACT OF CRYOPRESERVATION ON SERUM CONCENTRATION OF
BIOMARKERS MMP-7, TIMP-1, VEGF AND VEGF-R2 IN BIOBANK
K. Kisand1, K. Alnek1, J. Krjukova1, I. Kerna2, J. Kumm2, H. Jonsson3,
A.O. Tamm2
1Univ. of Tartu, Dept. of Immunology, Tartu, Estonia; 2Univ. of Tartu, Dept. of
Internal Med., Tartu, Estonia; 3Univ. of Iceland, Dept. of Rheumatology,
Reykjavik, Iceland
Purpose: In longitudinal studies like in osteoarthritis, serum samples are
collected over time, freezed (at-20°C) or deep-freezed (at -75°C or more),
and then simultaneously analyzed in order to minimize inter-assay vari-
ability. Unfortunately not much information has been published about the
impact of freezing and storage duration on biomarkers. In this study, we
investigated whether repeated freeze-thaw cycles or duration and temper-
ature of cryopreservation have an effect on the concentration of MMP-7,
TIMP-1, VEGF and VEGF-R2 measured in serum by ELISA.
Methods: Concentrations of biomarkers were measured by ELISA (R&D)
in the sera of patients with rheumatoid arthritis. To test stability, the
samples were frozen and thawed up to 6 times (0, 1, 3 and 6). Impact
of storage time/temperature was investigated using accelerated stability
testing protocol keeping samples at +4°C, +20°C, +30°C and +40°C up to 3
weeks. The stability for storage at -20°C and at -75°C was calculated using
Arrhenius equation (Kenis, G. et al., 2002) and the stability was expressed
as the period of time preserving at least 90% of the initial level of the
biomarker.
Results: One thawing cycle did not change signiﬁcantly concentration of
MMP-7 and VEGF-R2 measured by ELISA. But the level of these biomarkers
increased 20-24% after repeated thawing (3 or more cycles). The average
concentration of TIMP-1 decreased less than 13% even after 6 cycles of
thawing/freezing, but remarkable heterogeneity in deviation (increasing
or decreasing) from initial level was seen between individual sera. The
decrease in VEGF concentration (average 67%, from 30 to 95%) was very
remarkable even already after the ﬁrst thawing/freezing cycle.
The results of accelerated aging experiments were used to calculate the
liable concentration changes in cryopreservation of investigated biomark-
ers. According to Arrhenius’ calculation MMP-7 showed excellent stability
(at least 11 years at -20°C and several hundreds of years at -75°C !).
TIMP-1 keeps 90% of initial concentration at -20°C within one month and
10 months at -75°C. VEGF- R2 was more stable than VEGF and preserved at
-20°C within three months and at -75°C - 32 years (VEGF - one month and
4 months, respectively).
Conclusions: The conditions of storage of human sera in biobank should
be taken into account in the interpretation of the concentration of MMP-7,
TIMP-1, VEGF or VEGF-R2. Temperature -20 °C is not suitable for prolonged
storage of investigated biomarkers, except MMP-7.
VEGF-R2 and MMP-7 can be assessed in serum samples kept at -75 °C for
several decades. Repeated freezing of sera is not recommended as it may
increase the measured level of these biomarkers.
Assessment of TIMP-1 should be done within 10 months of storage at -75
°C. VEGF is not marker to test in cryopreserved sera as it is not stable at
thawing/freezing.
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VALIDATION OF BLOOD BIOMARKERS IN KNEE OSTEOARTHRITIS
Y.-M. Pers1,2, S. Fabre1, F. Djouad2, I. Duroux-Richard2, F. Apparailly2,
D. Noel2, C. Jorgensen1,2
1Unité Thérapeutique Clinique des Maladies Ostéoarticulaires, Montpellier,
France; 2INSERM U844, Montpellier, France
Purpose: In osteoarthritis (OA), many studies were focused in ﬁnding one
or more biomarkers reﬂecting the importance and the disease progression.
The aim of our study was to validate a number of these biomarkers.
Methods: Serum samples and fresh blood were obtained from 30 patients
with severe knee osteoarthritis (score of Kellgren/Lawrence K/L at least
3/4), 12 moderate knee OA patients (score of K/L less than 3) and 12
healthy donors as controls. We analyzed the systemic expression of CRP,
COMP, MMP-1 and MMP-3, osteocalcin, OPG, and CTX-I in the 3 groups
of patients by ELISA technique. Statistical analysis used the nonparametric
Wilcoxon test.
Results: OA patients had a mean age of 71 years, had a mean radiological
score of K/Lawrence of 3.8 and their pain has evolved over 7 years. Respec-
tively, moderate OA patients had 62 years, K/L score of 1,5 and 6 years
of pain. Compared to controls subjects, we found a signiﬁcant association
between the presence of a severe knee OA and serum levels of CRP (mean
8.8 vs 1.7 mg/L; p<0.001), OPG (mean 7.9 vs 5.4 ng/mL; p<0.001), MMP-3
(mean 32.4 vs 20.6 ng/mL; p<0.05) and COMP (mean 2.55 vs 2.05 μg/mL;
p<0.01). This association also exists with a low serum CTX-I (mean 0.42 vs
0.61 ng/mL; p<0.05). There was also a signiﬁcant association between the
presence of a moderate knee OA and serum levels of CRP (mean 2.6 vs 1.7
mg/L), OPG (mean 6.4 vs 5.4 ng/mL) and COMP (mean 2.43 vs 2.05 μg/mL)
(p<0,05). However, we did not ﬁnd any signiﬁcant association with low
levels of serum CTX-I or high levels of MMP-3.
Conclusions: Our results show the sensitivity of some biomarkers (bone,
cartilage or inﬂammation) to distinguish OA patients from healthy subjects.
Future work is needed to understand the pathophysiological mechanisms
involved in OA, particularly towards RANKL/OPG.
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PATHOGENESIS OF OSTEOARTHRITIS IN THE SEDC HETEROZYGOUS
MOUSE: A NEW ANIMAL MODEL
D. Holt, M. Henderson, R. Seegmiller
Brigham Young Univ., Provo, UT
Purpose: The purpose of this study was to establish the sedc heterozy-
gous (s/+) mouse as a new non-dwarfed, murine model for the study
of osteoarthritis (OA). In addition, this study was done to determine the
involvement of the HtrA-1, DDR-2 and MMP-13, known biomarkers of OA,
in the degenerative pathway of articular cartilage (AC) in the s/+ mouse
as compared to the wild-type (+/+) mouse. HtrA-1 is involved in the
destruction of the pericellular matrix surrounding chondrocytes. DDR-2 is
a cell membrane receptor protein that binds to type II collagen and triggers
the upregulation of MMP-13, which hydrolyzes type II collagen and some
proteoglycans.
Methods: The sedc heterozygote knee joint was analyzed using histological
techniques. To compare skeletal development of the s/+ mouse compared
with +/+ controls, full skeletal staining was done and 2 week growth
plates were analyzed using safranin O and fast green. Tissue sections from
mice at 2, 6, 9, 12 and 18 months of age were stained with safranin O
and fast green and analyzed with a modiﬁed Mankin scoring procedure
to compare the severity of OA in the s/+ knee joint with +/+ controls.
Immunohistochemistal (IHC) staining was used to identify the correlation
between OA and the relative upregulation of HtrA-1, DDR-2 and MMP-13.
Results: The sedc heterozygous mouse was phenotypically identical to +/+
controls in skeletal and gowth plate staining. Skeletal development was
normal, however, Mankin scoring showed a signiﬁcantly higher score in s/+
mice compared to +/+ controls at all ages. Scoring increased uniformly from
2 to 18 months. Safrinin O and fast green staining showed proteoglycan
degradation starting as early as 2 months and ﬁbrillation starting as early
as 9 months, but primarily occurring at 12 months. IHC showed that
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cartilage in s/+ animals have upregulated production of HtrA-1, DDR-2,
and MMP-13. HtrA-1 and DDR-2 are signiﬁcantly upregulated in 6 month
s/+ animals compared to +/+ animals. Following upregulation at 6 and
9 months, HtrA-1 and DDR-2 are less prevalent at 12 months. MMP-13
upregulation begins at 6 months of age and continues to 12 months. The
upregulation of biomarkers seen using IHC precede major OA changes,
which may lead to the degeneration of articular cartilage.
Conclusions: It was established that the s/+ mouse shows signs of prema-
ture OA development and was found to be a non-dwarfed, murine model
useful in studying the pathogenesis of OA. Additionally, the upregulation
of HtrA-1, DDR-2, and MMP-13 appear to play signiﬁcant roles in the
development of OA.
Biomechanics & Gait
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THE EFFECT OFWEIGHT LOSS ON KNEE JOINT LOADING IN OBESE KNEE
OSTEOARTHRITIS PATIENTS
J. Aaboe1, H. Bliddal1, T. Alkjær2, B.F. Riecke1, P. Christensen1,
H. Gudbergsen1, R. Christensen1, M. Henriksen1
1The Parker Inst., Frederiksberg, Denmark; 2Dept. of NeuroSci. and
Pharmacology, University of Copenhagen, Denmark
Purpose: Obesity is considered a risk factor in knee osteoarthritis patho-
genesis, but the evidence of obesity as a risk factor for knee osteoarthritis
progression is inconsistent. In obese knee osteoarthritis patients the combi-
nation of increased load and changed joint biomechanics may be regarded
as an underlying principle for the risk of disease progression. The de-
terminative role of gait biomechanics, in particular knee joint loads, in
knee osteoarthritis progression is generally accepted. Further, weight loss
is recommended as treatment of choise among non-surgical interventions.
Only few studies have investigated the effect of weight loss on knee joint
loading and among these only effects of relatively small weight losses were
studied. Accordingly, the purpose of this study was to investigate the effect
of a signiﬁcant weight loss obtained during a short period of time on knee
joint loading in obese knee osteoarthritis patients.
Methods: Patients referred to an intense 16 weeks dietary weight loss
program were included. To estimate effects of weight loss on knee joint
loading three-dimensional gait analyses were performed before and after
the intervention. The primary outcome is change in total knee joint loading,
measured at self-selected walking speed. Knee joint forces were estimated
using standard inverse dynamics, and a statically determinant knee model.
Per protocol mixed linear regression analyses were performed relating the
change in body mass to the change in knee joint loads. The analysis was
repeated adjusting for knee joint mechanical axis, age, gender and change
in walking speed and pain were included. From the regression analyses the
slopes of the linear best ﬁt regression lines were the outcomes.
Results: 192 (BMI>30) patients were included in the diet intervention
study and of those, 156 patients, with a baseline gait analysis, completed
the intervention. The mean baseline body mass of the 156 patients was
101.4 kg (95% CI 99.1 to 103.6). After the intervention the mean body mass
was 87.8 kg (95% CI 85.8 to 89.9) and the average weight loss was 13.7
kg (CI -14.4 to -12.9) corresponding to 13.5%. The average reduction in
knee joint loading was 220.9 N (95% CI -312.4 to -118.0). The unadjusted
Figure 1. Best linear ﬁt regression line, with beta-coeﬃcient = -23.969 (P=0.010), for the
association between weight loss and change in dynamic knee joint loading.
regression analyses showed a signiﬁcant association between change in
body mass and change in knee joint loading with a slope value of 20.3 N
(95% CI 0.4 to 40.2; P=0.048). The adjustment for covariates did not change
these results and a signiﬁcant association between change in body mass
and change in knee joint loading was observed (ﬁgure 1). The slope of the
linear regression line shows that a weight loss of 9.81 N (1 kg) results in a
24.0 N (95% CI 6.0 to 42.0; P=0.010) reduction in knee joint loading.
Conclusions: These data show that the reduction in the load exerted on
the knee is aproximately twice as could be explained by loss in body mass
alone. A large weight loss achieved in a short amount of time is clinical
relevant in order to reduce the total knee joint load during walking in
obese knee osteoarthritis patients.
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GAIT ALTERATIONS AND THEIR ASSOCIATIONWITH RADIOGRAPHIC
SEVERITY AND PAIN IN UNILATERAL HIP OSTEOARTHRITIS
N. Shakoor, K.C. Foucher, M.A. Wimmer, R.A. Mikolaitis, S. Khandelwal,
J.A. Block
Rush Med. Coll., Chicago, IL
Purpose: Biomechanical alterations, in particular those of gait and dynamic
joint loading, are important factors in the pathogenesis of lower extrem-
ity osteoarthritis (OA). For example, at the knee, the external adduction
moment is a validated and widely used surrogate marker of medial com-
partment knee loading, and has been associated with radiographic severity,
pain, and progression in knee OA. However, such a marker has not yet
evolved in hip OA and much less is known about the association of gait
alterations in hip OA with symptomatic and structural disease. Here, we
evaluate dynamic hip loading in unilateral hip OA vs. normal controls, and
characterize the association with pain and radiographic severity.
Methods: 64 participants with symptomatic unilateral hip OA and asymp-
tomatic knees were evaluated. Standard AP pelvic radiographs were scored
for Kellgren Lawrence (KL) grade at the hips, and site-directed WOMAC
pain visual analog scale was completed for the index hip. Gait analyses
were performed using an optoelectronic camera system and multicompo-
nent force plate. Participants walked at their normal walking speed. Peak
joint moments were calculated using inverse dynamics, and moments were
adjusted to body weight times height (%BW*ht) to allow for comparisons
between participants. 32 control participants of similar age, but without OA
or symptoms were also evaluated. Paired samples t-tests and independent
samples t-tests were used to make comparisons within participant and
between normals, respectively. Pearson and Spearman correlations were
used to evaluate relationships between gait variables, pain and KL severity.
Results: The 64 participants with hip OA (26 M; 38 F) had a mean age
(SD) of 62±11 yrs. 20 had KL 2, 21 had KL 3 and 23 had KL 4 hip OA.
The 32 controls (16 M; 18 F) had a mean age (SD) of 60±6 yrs. Data
from the affected hip and contralateral limb of the OA group and that of
control participants are summarized in the Table. Peak joint moments were
signiﬁcantly lower at the affected hip of hip OA participants, compared
to the contralateral unaffected hip, as well as compared to the hips of
control participants (p<0.05 as noted in Table). Gait speed, as expected,
was signiﬁcantly less in the hip OA group compared to controls. Linear
regression was used to adjust for speed, stride and hip range of motion
on differences in the moments between the groups. Results remained the
same after this adjustment, except that the hip external rotation moment
and hip ﬂexion moment were no longer signiﬁcantly different between the
hip OA and control groups (p>0.05). Finally, KL grade at the affected hip
was inversely associated with the hip adduction (rho=-0.410), hip ﬂexion
(rho=-0.387), hip internal rotation (rho=-0.457) and hip external rotation
Table 1
Affected hip Contralateral hip Control
Gait speed (meters/second) 1.09±0.15+ 1.11±0.18+ 1.21±0.20
Stride (meters/height) 0.73±0.06+ 0.74±0.07+ 0.80±0.08
Cadence (steps/minute) 106±12 106±12 107±11
Hip range of motion (degrees) 22±9*+ 30±6 32±5
Hip adduction moment (%BW*ht) 3.12±0.98*+ 3.43±0.95+ 5.03±0.94
Hip abduction moment (%BW*ht) 1.65±0.86 1.76±0.90 1.60±0.72
Hip ﬂexion moment (%BW*ht) 4.92±1.56*+ 5.79±2.11 6.21±1.66
Hip extension moment (%BW*ht) 2.11±0.93+ 2.23±0.90+ 3.71±1.58
Hip internal rotation moment (%BW*ht) 0.49±0.33*+ 0.62±0.38+ 0.91±0.30
Hip external rotation moment (%BW*ht) 0.40±0.40+ 0.48±0.28+ 0.65±0.35
*p<0.05 compared to contralateral; +p<0.05 compared to control.
